These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8192579)

  • 1. The role of investigative toxicology in pharmaceutical industry.
    Harpur ES; Bonner FW
    Arch Toxicol Suppl; 1994; 16():176-82. PubMed ID: 8192579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety pharmacology investigations in toxicology studies: an industry survey.
    Authier S; Vargas HM; Curtis MJ; Holbrook M; Pugsley MK
    J Pharmacol Toxicol Methods; 2013; 68(1):44-51. PubMed ID: 23685201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing drug discovery by Investigative Toxicology: Current and future trends.
    Beilmann M; Boonen H; Czich A; Dear G; Hewitt P; Mow T; Newham P; Oinonen T; Pognan F; Roth A; Valentin JP; Van Goethem F; Weaver RJ; Birk B; Boyer S; Caloni F; Chen AE; Corvi R; Cronin MTD; Daneshian M; Ewart LC; Fitzgerald RE; Hamilton GA; Hartung T; Kangas JD; Kramer NI; Leist M; Marx U; Polak S; Rovida C; Testai E; Van der Water B; Vulto P; Steger-Hartmann T
    ALTEX; 2019; 36(2):289-313. PubMed ID: 30570669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug safety Africa: An overview of safety pharmacology & toxicology in South Africa.
    Guth BD; Grobler AF; Frazier KS; Greiter-Wilke A; Herzyk D; Hough TA; Khan AA; Markert M; Smith JD; Svenson KL; Wells S; Pugsley MK
    J Pharmacol Toxicol Methods; 2019; 98():106579. PubMed ID: 31085319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing computational toxicology models with phytochemicals.
    Valerio LG; Arvidson KB; Busta E; Minnier BL; Kruhlak NL; Benz RD
    Mol Nutr Food Res; 2010 Feb; 54(2):186-94. PubMed ID: 20024931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Priorities in the development of alternative methodologies in the pharmaceutical industry.
    Jackson MR
    Arch Toxicol Suppl; 1998; 20():61-70. PubMed ID: 9442282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk assessment of carcinogens: present status and future directions.
    Munro IC
    Biomed Environ Sci; 1988 Jun; 1(1):51-8. PubMed ID: 3077260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancing toxicology in RiskMAPP: setting ADEs based on the subsequent drug substance.
    Bercu JP; Sharnez R; Dolan DG
    Regul Toxicol Pharmacol; 2013 Feb; 65(1):157-61. PubMed ID: 22921793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An EU perspective on the use of in vitro methods in regulatory pharmaceutical toxicology.
    Snodin DJ
    Toxicol Lett; 2002 Feb; 127(1-3):161-8. PubMed ID: 12052654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are multimetabolite methods fit-for-purpose for supporting toxicology studies?
    Smith G
    Bioanalysis; 2011 Dec; 3(24):2701-4. PubMed ID: 22185267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk assessment and regulatory decision making.
    Munro IC; Krewski DR
    Food Cosmet Toxicol; 1981 Oct; 19(5):549-60. PubMed ID: 7308901
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel genomic methods for drug discovery and mechanism-based toxicological assessment.
    Gant TW; Zhang SD; Taylor EL
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):72-80. PubMed ID: 19152215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of genetically altered models as replacement for the lifetime mouse bioassay in pharmaceutical development.
    Alden C; Smith P; Morton D
    Toxicol Pathol; 2002; 30(1):135-8. PubMed ID: 11890466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evolving role of investigative toxicology in the pharmaceutical industry.
    Pognan F; Beilmann M; Boonen HCM; Czich A; Dear G; Hewitt P; Mow T; Oinonen T; Roth A; Steger-Hartmann T; Valentin JP; Van Goethem F; Weaver RJ; Newham P
    Nat Rev Drug Discov; 2023 Apr; 22(4):317-335. PubMed ID: 36781957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal studies in safety pharmacology and toxicology: A survey conducted in the top 15 pharmaceutical companies.
    Benjamin A; Gallacher DJ; Greiter-Wilke A; Guillon JM; Kasai C; Ledieu D; Levesque P; Prelle K; Ratcliffe S; Sannajust F; Valentin JP
    J Pharmacol Toxicol Methods; 2015; 75():101-10. PubMed ID: 25637943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation challenges for designing integrated in vitro testing strategies (ITS) aiming at reducing and replacing animal experimentation.
    De Wever B; Fuchs HW; Gaca M; Krul C; Mikulowski S; Poth A; Roggen EL; Vilà MR
    Toxicol In Vitro; 2012 Apr; 26(3):526-34. PubMed ID: 22269383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational science in drug metabolism and toxicology.
    Valerio LG
    Expert Opin Drug Metab Toxicol; 2010 Jul; 6(7):781-4. PubMed ID: 20465524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications of hormesis in toxicology, risk assessment and chemotherapeutics.
    Calabrese EJ; Baldwin LA
    Trends Pharmacol Sci; 2002 Jul; 23(7):331-7. PubMed ID: 12119154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occupational toxicology: test methods and approaches for the pharmaceutical industry.
    Sprague G; Sutton T
    Occup Med; 1997; 12(1):119-29. PubMed ID: 9153057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.